Insider Monkey
H.C. Wainwright Initiates Coverage on Acrivon Therapeutics (ACRV) With “Buy” Rating and $19 PT
📈
AI Sentiment
Highly Positive
8/10
Acrivon Therapeutics Inc. News
Latest updates and market news for ACRV
1 news
Nov 26 - Dec 2, 2025
Page 1
Share this news page